The NDC is an FDA standard for uniquely identifying drugs in the United States. Currently, NDCs assigned by FDA contain 10 digits. NDCs consist of three segments: the labeler code, the product code, and the package code. At some point in the next 10 to 15 years, NDC formatting will need to be updated. The widespread use and dependency on NDCs in prescribing, dispensing, reimbursement, safety, clinical management, pharmaceutical manufacturing and labeling systems, the Agency is holding a public hearing and requesting comments from stakeholders moving toward an 11-digit NDC.
On November 5th FDA hosted a public hearing on how to evolve the future format of the NDC. RXTransparent presented its unique perspective of working with hundreds of healthcare customers as well as working with many partners in the drug supply chain giving us a cross-sectional view of the challenges associated with changing the NDC.